Multisite chronic pain and incident multiple sclerosis: A prospective cohort study

Fatemeh Vazirian1, Jing Tian1, Jane Alty2

  • 1Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS 7000, Australia.

Abstract

Insights

Chronic musculoskeletal pain is linked to a higher risk of developing multiple sclerosis (MS). This association, particularly with widespread pain, is partly explained by inflammation, suggesting a shared neuroimmune process.

Area of Science:

  • Neuroimmunology
  • Epidemiology
  • Pain Medicine

Background:

  • Chronic musculoskeletal pain is prevalent in multiple sclerosis (MS) and may influence neurodegeneration.
  • The relationship between chronic pain and the subsequent development of MS is not well understood.

Purpose of the Study:

  • To investigate the association between chronic pain and the incidence of MS.
  • To determine if systemic inflammation mediates the relationship between chronic pain and MS.

Main Methods:

  • Analysis of UK Biobank data from 356,010 participants without MS at baseline.
  • Categorization of participants based on the number of chronic pain sites (≥3 months).
  • Cox regression and mediation analysis to assess associations and the role of inflammation.

Main Results:

  • Chronic pain was associated with a 26% increased risk of developing MS.
  • A dose-response relationship was observed, with pain in multiple sites significantly increasing MS risk.
  • Inflammation partially mediated the association, with varying effects across inflammatory markers.

Conclusions:

  • Chronic musculoskeletal pain is a significant predictor of later MS diagnosis, especially when widespread.
  • Peripheral inflammation plays a partial role in this association.
  • Chronic pain may indicate an early risk for MS, reflecting shared neuroimmune pathways.